Patent · US Active

Cancer evaluation method and cancer evaluation system

US10845372B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2015
Grant dateNov 24, 2020
Priority date
Expiry dateApr 18, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/57488
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A cancer evaluation method includes a step S1 of measuring the concentrations of a set of evaluation elements in a serum sample 2 taken from a subject, a step S2 of applying the concentration data of the set of elements to a predetermined discriminant function to perform an operation; and a step S3 of discriminating whether or not the subject suffers from any type of cancer based on the operation result obtained using the concentration data and the discriminant function. The discrimination is carried out in accordance with the concentration balance (pattern) of the set of elements. Preferably, the set of elements are 7 elements of S, P, Mg, Zn, Cu, Ti, and Rb, or 16 elements of Na, Mg, Al, P, K, Ca, Ti, Mn, Fe, Zn, Cu, Se, Rb, Ag, Sn, and S.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.